Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012-2018
- PMID: 38488052
- DOI: 10.1089/jwh.2023.0643
Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012-2018
Abstract
Background: To address reimbursement challenges associated with long-acting reversible contraception (LARC) in the postpartum period, state Medicaid programs have provided additional payments ("carve-outs"). Implementation has been heterogeneous, with states providing separate payments for the device only, procedure only, or both the device and procedure. Methods: Claims data were drawn from 210,994 deliveries in the United States between 2012 and 2018. Using generalized estimating equations, we assess the relationship between Medicaid carve-out policies and the likelihood of LARC placement at (1) 3 days postpartum, (2) 60 days postpartum, and (3) 1 year postpartum, in Medicaid and commercially insured populations. Results: Among Medicaid beneficiaries, the likelihood of receiving LARC was higher in states with any carve-out, compared with states without carve-outs, at 3 days (adjusted odds ratio [aOR] 1.49 [95% confidence interval: 1.33-1.67], p < 0.001), 60 days (aOR: 1.40 [95% CI: 1.35-1.46], p < 0.001), and 1 year postpartum (aOR: 1.15 [95% CI: 1.11-1.20], p < 0.001). Adjustments were made for geographic region, seasonality, and patient age. Heterogeneity was observed by carve-out type; device carve-outs were consistently associated with greater likelihood of postpartum LARC placement, compared with states with no carve-outs. Similar trends were observed among commercially insured patients. Conclusion: Findings support the effectiveness of Medicaid carve-outs on postpartum LARC provision, particularly for device carve-outs, which were associated with increased postpartum LARC placement at 3 days, 60 days, and 1 year postpartum. This outcome suggests that policies to address cost-related barriers associated with LARC devices may prove most useful in overcoming barriers to immediate postpartum LARC placement, with the overarching aim of promoting reproductive autonomy.
Keywords: LARC; Medicaid policy; Symphony Health; carve-out; claims data; contraception; health policy; health services research.
Similar articles
-
Medicaid reimbursement program for immediate postpartum long-acting reversible contraception improves uptake regardless of insurance status.Contraception. 2022 Sep;113:57-61. doi: 10.1016/j.contraception.2022.05.007. Epub 2022 May 16. Contraception. 2022. PMID: 35588793
-
Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.Womens Health Issues. 2019 Nov-Dec;29(6):465-470. doi: 10.1016/j.whi.2019.07.006. Epub 2019 Sep 5. Womens Health Issues. 2019. PMID: 31495642
-
Medicaid Policy Change and Immediate Postpartum Long-Acting Reversible Contraception.JAMA Health Forum. 2024 Jun 7;5(6):e241359. doi: 10.1001/jamahealthforum.2024.1359. JAMA Health Forum. 2024. PMID: 38848089 Free PMC article.
-
Immediate Postpartum Long-Acting Reversible Contraception: Review of Insertion and Device Reimbursement Policies.Womens Health Issues. 2021 Nov-Dec;31(6):523-531. doi: 10.1016/j.whi.2021.09.001. Epub 2021 Oct 1. Womens Health Issues. 2021. PMID: 34602326 Free PMC article. Review.
-
Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.Acta Obstet Gynecol Scand. 2021 Apr;100(4):629-640. doi: 10.1111/aogs.14129. Epub 2021 Mar 9. Acta Obstet Gynecol Scand. 2021. PMID: 33608901
Cited by
-
Measuring abortion in claims data: What is the state of the science?Contraception. 2025 Feb;142:110750. doi: 10.1016/j.contraception.2024.110750. Epub 2024 Nov 15. Contraception. 2025. PMID: 39551368 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical